Israeli scientist identifies protein that could treat cancer

| September 13, 2013
arts pict x m
Image via No Camels.
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

“Killing these cancer stem cells is the holy grail of cancer treatments and therefore holds promise for complete eradication of cancer,” says Dr. Sarit Larisch of the University of Haifa.

These are not words pronounced lightly; instead, they follow more than a decade of research that could give hope to cancer patients worldwide. Along with her colleagues, Larisch has established the basis for developing a new, more effective treatment for cancer using a protein called ARTS.

The protein regulates the process of programmed cell death which occurs when a cell is damaged, mutated or no longer functional. This protein acts as a trigger for cell death, its presence allowing for enzymes called caspases to destroy the non-functional cell. An Israeli scientists has discovered that this process is missing in cancer cells, which means this new treatment could be the key that has alluded scientists for decades to finding a cure for cancer.

Read the full, original story here: Israeli Discovers Cell-Destroying Protein that Could End Cancer

 Additional Resources:

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend